Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.82 USD | -4.39% | +3.21% | +213.69% |
May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Press Releases